Hyperactivated AKT and PTEN loss have been reported in several cancers including pancreatic cancer and are associated with increased proliferation, metastasis, angiogenesis, cell growth and resistance to apoptosis [36]–[41]. Here, AKT1 is linked to familial pancreatic carcinoma.